|
Volumn 36, Issue 11, 2001, Pages 759-763
|
Treatment of chronic hepatitis C patients with amantadine
a a |
Author keywords
Amantadine; Antiviral therapy; Chronic hepatitis C
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
AMANTADINE;
ANTIVIRUS AGENT;
BIOCHEMICAL MARKER;
INTERFERON;
VIRUS RNA;
ACUTE DISEASE;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANOREXIA;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CATARACT;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
FEMALE;
HEPATITIS C;
HUMAN;
INSOMNIA;
MAJOR CLINICAL STUDY;
MALE;
MUSCLE WEAKNESS;
NAUSEA;
PARESTHESIA;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
TIME;
TREATMENT FAILURE;
VIREMIA;
VISUAL IMPAIRMENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ALANINE TRANSAMINASE;
AMANTADINE;
ANTIVIRAL AGENTS;
CATARACT;
COGNITION DISORDERS;
CONSTIPATION;
EATING DISORDERS;
FEMALE;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
HYPESTHESIA;
MALE;
MIDDLE AGED;
NAUSEA;
PROSPECTIVE STUDIES;
SLEEP INITIATION AND MAINTENANCE DISORDERS;
TIME FACTORS;
VISION DISORDERS;
|
EID: 0035210388
PISSN: 09441174
EISSN: None
Source Type: Journal
DOI: 10.1007/s005350170018 Document Type: Article |
Times cited : (15)
|
References (21)
|